Organization: Health Canada
Year: 2021
Month: August
Request Number: A-2021-000060
Request Summary: Adverse Reaction Report (AER) for Dexilant. Report number: 000934154. (ADR) for Vedolizumab. Report number: 000933837. (ADRs) for Ondansetron. Report numbers: E2B_03663702, 000933934, 000933444. (ADRs) for Pantoprazole Sodium. Report numbers: E2B_03673787, E2B_03687898. (ADRs) for Tecta. Report numbers: E2B_03692077, 000933488. (ADRs) for Pantoprazole Magnesium. Report numbers: 000934688, 000932879. (ADRs) for Mezavant. Report numbers: E2B_03690263, E2B_03683732, 000934953, E2B_03693954, E2B_03698133, 000935134, 000933007.
Disposition: Disclosed in part
Number of pages: 380